Re: Ann: Trading Halt, page-2

Someone else made the point but it just clicked for me. Last Cap Raise was 1/10/19 and on 19/10/19 MSB entered into agreement with Lonza for manufacturing of Ryoncil in preparation for commercial launch in paediatric GvHD. That was for $75mil in an indication immensely smaller than the current Covid-19 ARDS needs. I wonder if how much of that cap raise was prompted at the request of Lonza. By the same token I wonder if there was any promoting here and if there will be will be a subsequent announcement in 2 weeks announcing an agreement with Lonza for manufacturing Ryoncil in preparation for a commercial launch in ARDS.